George Pavlov 首席执行官在每季损失前几天购买了441K美元 马普林药剂公司库存。 CEO George Pavlov bought $441K in Maplight Therapeutics stock days before a quarterly loss.

George Pavlov在2026年2月18日至20日之间购买了24 990股, 花费约441 168美元, Maplight Therapeutics director George Pavlov purchased 24,990 shares between February 18 and 20, 2026, spending about $441,168, increasing his stake by 41.49% to 15,080 shares. 该公司侧重于中枢神经系统紊乱问题,报告季度损失每股37.18美元,缺少估计数,市场上限为8.1127亿美元,过去一年的库存范围为12.24至21.55美元。 The company, focused on central nervous system disorders, reported a quarterly loss of $37.18 per share, missing estimates, with a market cap of $811.27 million and a stock range of $12.24 to $21.55 over the past year. 分析师的前景好坏参半,具有协商一致的“机动购买”评级和31.00美元目标。 Analysts have a mixed outlook, with a consensus “Moderate Buy” rating and a $31.00 target.